Table 2.
Patients Keeping Next 2 Visits, % (No.) |
||||
---|---|---|---|---|
Variable | Preintervention Year (2008–2009) | Intervention Year (2009–2010) | % Relative Improvementa | P |
Overall (no adjustment) | 52.7 (8535) | 58.2 (9227) | 10.4 | <.0001 |
Overall (adjusted) | 49.3 (8535) | 52.7 (9227) | 7.0 | <.0001 |
Patient type | ||||
New or reengaging | 45.2 (1147) | 57.9 (1210) | 28.2 | <.0001 |
Active | 48.1 (7388) | 50.6 (8017) | 5.3 | <.0001 |
Viral loadb | ||||
Undetectablec | 57.2 (5537) | 60.4 (6287) | 5.6 | <.0001 |
Detectable | 44.4 (2998) | 51.5 (2940) | 16.0 | <.0001 |
CD4 cell count,b cells/mm3 | ||||
<350 | 49.8 (3443) | 55.0 (3616) | 10.3 | <.0001 |
≥350 | 53.3 (5012) | 56.4 (5376) | 5.7 | <.0001 |
Scheduled visits for care, No. | ||||
2–3d | 52.6 (3270) | 55.1 (4098) | 4.7 | .003 |
4–6 | 49.4 (3589) | 53.4 (3600) | 8.2 | <.0001 |
≥7 | 45.4 (1676) | 50.8 (1529) | 12.0 | .001 |
Sex | ||||
Male | 52.6 (5491) | 56.3 (5909) | 7.0 | <.0001 |
Female | 50.1 (3012) | 54.7 (3304) | 9.1 | <.0001 |
Age group, years | ||||
16–29 | 40.5 (470) | 48.6 (577) | 19.9 | .006 |
30–39 | 45.9 (1485) | 51.4 (1534) | 11.9 | .0003 |
40–49 | 50.9 (3201) | 54.6 (3299) | 7.2 | .0006 |
50–85 | 57.0 (3379) | 60.5 (3817) | 6.1 | .0002 |
Race/ethnicity | ||||
Black | 50.1 (5542) | 54.6 (6061) | 9.0 | <.0001 |
White | 53.3 (1307) | 56.5 (1327) | 6.0 | .018 |
Other race | 48.8 (108) | 61.2 (121) | 25.2 | .022 |
Hispanic | 50.7 (1578) | 53.5 (1718) | 5.5 | .040 |
HIV risk group | ||||
MSM | 55.6 (2273) | 57.0 (2432) | 2.5 | .224 |
MSM plus IDUs | 54.1 (198) | 55.3 (193) | 2.2 | .780 |
Othere | 48.2 (659) | 55.7 (755) | 15.5 | .004 |
Heterosexuals | 51.7 (4228) | 56.6 (4636) | 9.5 | <.0001 |
IDUs | 42.9 (1177) | 48.0 (1211) | 11.8 | .004 |
Insurance | ||||
Private | 54.5 (1315) | 57.9 (1354) | 6.3 | .010 |
Medicare | 51.3 (1916) | 54.2 (1968) | 5.5 | .013 |
Medicaid | 43.3 (2891) | 47.8 (3091) | 10.6 | <.0001 |
Other/RW/nonef | 46.4 (2413) | 50.1 (2814) | 8.0 | .002 |
Model adjusted for age, viral load, number of scheduled appointments, insurance, and clinic site. Missing data on age, viral load, and insurance are excluded from the table. Patients with a single postanchor scheduled appointment were also excluded.
Abbreviations: HIV, human immunodeficiency virus; IDUs, injection drug users; MSM, men who have sex with men; RW, Ryan White coverage.
a Change in retention measure from preintervention period to intervention period, expressed as a percentage of the measure for the preintervention period.
b Based on clinical records no more than ±99 days from anchor visit in preintervention and intervention periods.
c Undetectable viral loads were defined as HIV RNA levels ≤400 copies/mL.
d Patients with only a single postanchor scheduled visit were not included in this model.
e “Other” category includes other risk factors, unknown or undetermined risk factors, and no risk factors identified.
f For insurance, “other” includes university and local charity programs.